Is a complete CTSO research report available?

No complete published report is available for Cytosorbents Corporation (CTSO) on this page. Market-directory data, when present, is not a substitute for a validated stock analysis.

Cytosorbents Corporation (CTSO)

NASDAQ: CTSO · USD

$5.38

+0.53 (+10.9%)· Recorded snapshot

Market cap	17M
Revenue (ttm)	37.2M
Net income (ttm)	-18.2M
EPS (ttm)	-$5.82
Shares out	3.2M
Volume	21,453
Beta	1.37

Market data

Price

Recent price action with selectable time range.

Financial snapshot

Revenue (ttm): 37.2M
Net income (ttm): -18.2M
EPS (ttm): -$5.82
Market cap: 17M

Ticker	Name	Market cap	P/E	P/S	ROIC	5Y rev CAGR	1Y total return	Rating
EXAS	Exact Sciences Corp	—	—	—	—	—	—	Держать

Metric	Value
Amount currency	USD
CIK code	0001175151
Company name	Cytosorbents Corporation
Country	United States
Country code	US
CUSIP number	23283X305
Earnings date	2026-11-12
Earnings time	amc
Employees	129
Employees change	-20
Employees growth	-13.42%
Enterprise value	$42M
Exchange	NASDAQ
Financial currency	USD
Financial report date	2026-06-30
First seen	2026-05-09
Fiscal year end	December
Founded	1997
Industry	Medical Devices
Is primary listing	Yes
Is SPAC	No
ISIN number	US23283X3052
Last 10-K release date	2026-03-30
Last earnings date	2026-08-06
Last refreshed	2026-10-28
Last stock split date	2026-09-08
Last stock split type	Reverse
Market cap	$17M
Market cap category	Nano-Cap
Next earnings date	2026-11-12
Options	Yes
Price	$5.38
Price currency	USD
Sector	Healthcare
SIC code	3841
Stock price date	2026-10-28
Symbol	CTSO
U.S. state	New Jersey
Website	https://www.cytosorbents.com

Metric

Value

Amount currency

USD

CIK code

0001175151

Company name

Cytosorbents Corporation

Country

United States

Country code

CUSIP number

23283X305

Earnings date

2026-11-12

Earnings time

amc

Employees

129

Employees change

-20

Employees growth

-13.42%

Enterprise value

$42M

Exchange

NASDAQ

Financial currency

USD

Financial report date

2026-06-30

First seen

2026-05-09

Fiscal year end

December

Founded

1997

Industry

Medical Devices

Is primary listing

Yes

Is SPAC

ISIN number

US23283X3052

Last 10-K release date

2026-03-30

Last earnings date

2026-08-06

Last refreshed

2026-10-28

Last stock split date

2026-09-08

Last stock split type

Reverse

Market cap

$17M

Market cap category

Nano-Cap

Next earnings date

2026-11-12

Options

Yes

Price

$5.38

Price currency

USD

Sector

Healthcare

SIC code

3841

Stock price date

2026-10-28

Symbol

CTSO

U.S. state

New Jersey

Website

https://www.cytosorbents.com

Metric	Value
Earnings yield	-108.22%
EV/Sales	1.08x
FCF / EV yield	-23.07%
FCF yield	-60.83%
Forward EV/Sales	0.95x
Forward P/S	0.36x
Industry forward P/E	19.81x
Industry P/E	39.5x
P/S ratio	0.41x
Sector forward P/E	23.56x
Sector P/E	50.08x

Metric

Value

Earnings yield

-108.22%

EV/Sales

1.08x

FCF / EV yield

-23.07%

FCF yield

-60.83%

Forward EV/Sales

0.95x

Forward P/S

0.36x

Industry forward P/E

19.81x

Industry P/E

39.5x

P/S ratio

0.41x

Sector forward P/E

23.56x

Sector P/E

50.08x

Metric	Value
EBIT margin	-31.63%
EBITDA margin	-27.81%
Gross margin	71.61%
Operating margin	-31.63%
Pretax margin	-50.02%
Profit margin	-48.94%
Profit per employee	$-141,194
Revenue per employee	$288,496
ROA	-17.12%
ROA (5Y)	-23.09%
ROCE	-84.46%
ROE	-336.21%
ROE (5Y)	-83.44%
ROIC	-21.86%
SBC / revenue	6.14%
Tax / revenue	-1.08%

Metric

Value

EBIT margin

-31.63%

EBITDA margin

-27.81%

Gross margin

71.61%

Operating margin

-31.63%

Pretax margin

-50.02%

Profit margin

-48.94%

Profit per employee

$-141,194

Revenue per employee

$288,496

ROA

-17.12%

ROA (5Y)

-23.09%

ROCE

-84.46%

ROE

-336.21%

ROE (5Y)

-83.44%

ROIC

-21.86%

SBC / revenue

6.14%

Tax / revenue

-1.08%

Metric	Value
EPS growth years	3
Gross profit growth	8.63%
Gross profit growth (Q)	3.45%
Gross profit growth 3Y	8.53%
Gross profit growth 5Y	-4.89%
Net income growth years	3
Revenue growth	3.07%
Revenue growth (Q)	0.17%
Revenue growth (QoQ)	8.68%
Revenue growth 10Y	17.96%
Revenue growth 3Y	0.77%
Revenue growth 5Y	-3.78%
Revenue growth quarters	5
Revenue growth years	2

Metric

Value

EPS growth years

Gross profit growth

8.63%

Gross profit growth (Q)

3.45%

Gross profit growth 3Y

8.53%

Gross profit growth 5Y

-4.89%

Net income growth years

Revenue growth

3.07%

Revenue growth (Q)

0.17%

Revenue growth (QoQ)

8.68%

Revenue growth 10Y

17.96%

Revenue growth 3Y

0.77%

Revenue growth 5Y

-3.78%

Revenue growth quarters

Revenue growth years

Metric	Value
Capital expenditures	$-150,000
Depreciation and amortization	$1.4M
EBIT	$-11.8M
EBITDA	$-10.3M
EPS	$-5.82
FCF per share	$-2.95
Financing cash flow	$2.5M
Free cash flow	$-9.3M
Free cash flow minus SBC	$-11.6M
Gross profit	$26.6M
Income taxes	$-401,000
Investing cash flow	$-275,000
Net borrowing	$2.5M
Net cash flow	$-5.8M
Net income	$-18.2M
Operating cash flow minus SBC	$-11.4M
Operating income	$-11.8M
Revenue	$37.2M
Stock-based compensation	$2.3M

Metric

Value

Capital expenditures

$-150,000

Depreciation and amortization

$1.4M

EBIT

$-11.8M

EBITDA

$-10.3M

EPS

$-5.82

FCF per share

$-2.95

Financing cash flow

$2.5M

Free cash flow

$-9.3M

Free cash flow minus SBC

$-11.6M

Gross profit

$26.6M

Income taxes

$-401,000

Investing cash flow

$-275,000

Net borrowing

$2.5M

Net cash flow

$-5.8M

Net income

$-18.2M

Operating cash flow minus SBC

$-11.4M

Operating income

$-11.8M

Revenue

$37.2M

Stock-based compensation

$2.3M

Metric	Value
Altman Z-Score	-11.45
Book value per share	$-0.24
Interest coverage	-3.78
Long-term assets	$22.2M
Long-term liabilities	$14.7M
Net cash (debt)	$-25M
Net cash / market cap	-163.67%
Piotroski F-Score	4
Property, plant and equipment	$17.8M
Shareholders' equity	$-751,000
Tangible book value	$-3.6M
Tangible book value per share	$-1.15
Total assets	$38M
Total cash	$4.4M
Total debt	$29.4M
Total liabilities	$38.7M
WACC	9.53%

Metric

Value

Altman Z-Score

-11.45

Book value per share

$-0.24

Interest coverage

-3.78

Long-term assets

$22.2M

Long-term liabilities

$14.7M

Net cash (debt)

$-25M

Net cash / market cap

-163.67%

Piotroski F-Score

Property, plant and equipment

$17.8M

Shareholders' equity

$-751,000

Tangible book value

$-3.6M

Tangible book value per share

$-1.15

Total assets

$38M

Total cash

$4.4M

Total debt

$29.4M

Total liabilities

$38.7M

WACC

9.53%

Metric	Value
Asset turnover	0.87
Current assets	$15.7M
Current liabilities	$24M
Current ratio	0.66
Inventory turnover	2.86
Net working capital	$2M
Quick ratio	0.47
Working capital	$-8.3M
Working capital turnover	15.32

Metric

Value

Asset turnover

0.87

Current assets

$15.7M

Current liabilities

$24M

Current ratio

0.66

Inventory turnover

2.86

Net working capital

$2M

Quick ratio

0.47

Working capital

$-8.3M

Working capital turnover

15.32

Metric	Value
Buyback yield / dilution	-8%
Dividend yield	0%
Shareholder yield	-8%

Metric

Value

Buyback yield / dilution

-8%

Dividend yield

Shareholder yield

-8%

Metric	Value
10Y price change	-95.35%
10Y return CAGR	-26.42%
10Y total return	-95.35%
150-day SMA	$8.18
15Y price change	-93.18%
15Y return CAGR	-16.39%
15Y total return	-93.18%
1D price change	10.93%
1M price change	22.15%
1M total return	22.15%
1W price change	0.56%
1W total return	0.56%
1Y price change	-67.38%
1Y return CAGR	-67.4%
1Y total return	-67.38%
20-day SMA	$4.32
200-day SMA	$9.59
20Y price change	-99.26%
20Y return CAGR	-21.74%
20Y total return	-99.26%
3M price change	-25.69%
3M total return	-25.69%
3Y price change	-82.52%
3Y return CAGR	-44.08%
3Y total return	-82.52%
50-day SMA	$5.39
50-day SMA vs 200-day SMA	50under200
52-week high	$17.20
52-week high date	2025-10-28
52-week low	$2.84
52-week low date	2026-10-15
5Y price change	-95.42%
5Y return CAGR	-46.03%
5Y total return	-95.42%
6M price change	-56.29%
6M total return	-56.29%
All-time high	$1,000,000.00
All-time high date	2006-08-07
All-time low	$2.84
All-time low date	2026-10-15
Average true range (ATR)	$0.72
Average volume	70K
Beta (1Y)	1.39
Beta (2Y)	0.62
Beta (5Y)	1.37
Change from 52-week high	-68.72%
Change from 52-week low	89.44%
Change from all-time high	-100%
Change from all-time low	88.38%
Change from open	2.67%
Day's gap	8.04%
Dollar volume	$115,417
High price	$5.38
Low price	$5.24
Monthly RSI	35.35
Open price	$5.24
Position in 52-week range	100%
Premarket change	0%
Premarket close	$4.85
Premarket price	$4.85
Previous close	$4.85
Price vs 150-day SMA	-34.57%
Price vs 20-day SMA	23.79%
Price vs 200-day SMA	-44.22%
Price vs 50-day SMA	-0.69%
Relative volume	0.31
RSI	55.51
Sharpe ratio	-0.76
Sharpe ratio (3Y)	-0.31
Sharpe ratio (5Y)	-0.3
Sortino ratio	-1.09
Sortino ratio (3Y)	-0.39
Sortino ratio (5Y)	-0.38
Volume	21.5K
Weekly RSI	36.25
YTD price change	-58.15%
YTD total return	-58.15%

Metric

Value

10Y price change

-95.35%

10Y return CAGR

-26.42%

10Y total return

-95.35%

150-day SMA

$8.18

15Y price change

-93.18%

15Y return CAGR

-16.39%

15Y total return

-93.18%

1D price change

10.93%

1M price change

22.15%

1M total return

22.15%

1W price change

0.56%

1W total return

0.56%

1Y price change

-67.38%

1Y return CAGR

-67.4%

1Y total return

-67.38%

20-day SMA

$4.32

200-day SMA

$9.59

20Y price change

-99.26%

20Y return CAGR

-21.74%

20Y total return

-99.26%

3M price change

-25.69%

3M total return

-25.69%

3Y price change

-82.52%

3Y return CAGR

-44.08%

3Y total return

-82.52%

50-day SMA

$5.39

50-day SMA vs 200-day SMA

50under200

52-week high

$17.20

52-week high date

2025-10-28

52-week low

$2.84

52-week low date

2026-10-15

5Y price change

-95.42%

5Y return CAGR

-46.03%

5Y total return

-95.42%

6M price change

-56.29%

6M total return

-56.29%

All-time high

$1,000,000.00

All-time high date

2006-08-07

All-time low

$2.84

All-time low date

2026-10-15

Average true range (ATR)

$0.72

Average volume

70K

Beta (1Y)

1.39

Beta (2Y)

0.62

Beta (5Y)

1.37

Change from 52-week high

-68.72%

Change from 52-week low

89.44%

Change from all-time high

-100%

Change from all-time low

88.38%

Change from open

2.67%

Day's gap

8.04%

Dollar volume

$115,417

High price

$5.38

Low price

$5.24

Monthly RSI

35.35

Open price

$5.24

Position in 52-week range

100%

Premarket change

Premarket close

$4.85

Premarket price

$4.85

Previous close

$4.85

Price vs 150-day SMA

-34.57%

Price vs 20-day SMA

23.79%

Price vs 200-day SMA

-44.22%

Price vs 50-day SMA

-0.69%

Relative volume

0.31

RSI

55.51

Sharpe ratio

-0.76

Sharpe ratio (3Y)

-0.31

Sharpe ratio (5Y)

-0.3

Sortino ratio

-1.09

Sortino ratio (3Y)

-0.39

Sortino ratio (5Y)

-0.38

Volume

21.5K

Weekly RSI

36.25

YTD price change

-58.15%

YTD total return

-58.15%

Metric	Value
Float	2.8M
Float percentage	88.22%
Shares change (QoQ)	0.11%
Shares change (YoY)	8%
Shares held by insiders	11.78%
Shares held by institutions	24.62%
Shares outstanding	3.2M
Short % of float	4.12%
Short % of shares	3.63%
Short ratio	4.7 days

Metric

Value

Float

2.8M

Float percentage

88.22%

Shares change (QoQ)

0.11%

Shares change (YoY)

Shares held by insiders

11.78%

Shares held by institutions

24.62%

Shares outstanding

3.2M

Short % of float

4.12%

Short % of shares

3.63%

Short ratio

4.7 days

Cytosorbents Corporation (CTSO)

Price

Financial snapshot

Fair-value bridge

Latest news · CTSO

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All CTSO indicators

Profile and market data

Valuation

Profitability

Growth

Financial statements

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Ownership and float

Deeper analysis on CTSO

Frequently asked questions